Immunohistochemical analysis of human cancers showed the over-expression of Crk in adenocarcinomas of lung, breast, and stomach, and also sarcomas, followed by the demonstration of increased levels of Crk mRNA in more aggressive phenotypes of lung adenocarcinoma [62,190-194]. The gene discussed is CRK; the disease is lung adenocarcinoma.